Cargando…

PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma via Modulation of EphA2 Expression

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy and treatment failure is largely due to metastasis and invasion. Aberrant tumor cell adhesion is often associated with tumor progression and metastasis. However, the exact details of cell adhesion in ESCC progression have ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiao, Zhu, Yaning, Shen, Li, Zhou, Yu, Pang, Liqun, Zhou, Wubi, Gu, Hao, Han, Kairong, Yang, Yijun, Jiang, Chao, Xie, Jun, Zhang, Chengwan, Ding, Lianshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021923/ https://www.ncbi.nlm.nih.gov/pubmed/33833989 http://dx.doi.org/10.3389/fonc.2021.629916

Ejemplares similares

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration
por: Waller, Verena, et al.
Publicado: (2023)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
por: Bai, Yu-Qin, et al.
Publicado: (2015)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma
por: Liu, Lijun, et al.
Publicado: (2018)

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose
por: Lin, Qingtang, et al.
Publicado: (2021)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway
por: Zhang, Rui, et al.
Publicado: (2020)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling
por: Gao, Zicong, et al.
Publicado: (2021)

EphA3 Functions are Regulated by Collaborating Phosphotyrosine Residues
por: Shi, Guanfang, et al.
Publicado: (2010)

Epithelial-Mesenchymal Transition Regulated by EphA2 Contributes to Vasculogenic Mimicry Formation of Head and Neck Squamous Cell Carcinoma
por: Wang, Wei, et al.
Publicado: (2014)

Unliganded EphA3 dimerization promoted by the SAM domain
por: Singh, Deo R., et al.
Publicado: (2015)

EphA2 cleavage helps tumor cells go it alone
por: Short, Ben
Publicado: (2013)

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
por: Yi, Zhongzhen, et al.
Publicado: (2018)

EphA7 promotes myogenic differentiation via cell-cell contact
por: Arnold, Laura L, et al.
Publicado: (2020)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
por: Cui, Shuang, et al.
Publicado: (2021)

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
por: Holm, Ruth, et al.
Publicado: (2008)

Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
por: Zhou, Yue, et al.
Publicado: (2015)

EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway
por: Zhang, Rui, et al.
Publicado: (2020)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Anlotinib Inhibits Tumor Angiogenesis and Promotes the Anticancer Effect of Radiotherapy on Esophageal Cancer through Inhibiting EphA2
por: Gu, Zhenlin, et al.
Publicado: (2022)

EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
por: CHEN, PEIJIE, et al.
Publicado: (2014)

Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity
por: Ravasio, Andrea, et al.
Publicado: (2020)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
por: Cioce, Mario, et al.
Publicado: (2021)

Possible role of EphA4 and VEGFR2 interactions in neural stem and progenitor cell differentiation
por: Chen, Qingfa, et al.
Publicado: (2020)

The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells
por: Lee, Sang Hag, et al.
Publicado: (2021)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)

Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
por: Wilson, Kalin, et al.
Publicado: (2021)

Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration
por: Peng, Jing, et al.
Publicado: (2021)

Tsc2-Rheb Signaling Regulates EphA-Mediated Axon Guidance
por: Nie, Du-yu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gmfen49cj333cvbk4tptpk1skc